Skip to main content
×
×
Home

Does drug treatment reduce the risk of further self-harm or suicide?: Commentary on… Cochrane Corner

  • Katharine Smith and Mary Jane Attenburrow
Summary

Self-harm is a significant social and healthcare problem, with substantial morbidity and healthcare costs. It has strong links to further self-harm and to suicide. The current review is one of three that investigate interventions in preventing recurrence of self-harm, and it focuses on pharmacological treatment. The conclusions are limited by the small number and size of trials identified, and the low quality of evidence. No benefit on recurrence of self-harm was detected in three small trials of antidepressants, but the types studied are ones that are now less commonly used. A small trial of flupentixol suggested a possible benefit on repetition, but this has not been replicated. One small trial of lithium showed no benefit, but this was in contrast to a recent large meta-analysis showing a significant anti-suicidal effect of lithium when used to treat mood disorder. The review highlights important areas for further research.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Does drug treatment reduce the risk of further self-harm or suicide?
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Does drug treatment reduce the risk of further self-harm or suicide?
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Does drug treatment reduce the risk of further self-harm or suicide?
      Available formats
      ×
Copyright
Corresponding author
Dr Katharine Smith, NIHR Oxford cognitive health Clinical Research Facility, Warneford Hospital, Oxford OX3 7JX, UK. Email: katharine.smith@psych.ox.ac.uk
Footnotes
Hide All

DECLARATION OF INTEREST

None

See p. 2, this issue.

Footnotes
References
Hide All
Carroll, R, Metcalfe, C, Gunnell, D (2014) Hospital presenting self-harm and risk of fatal and non-fatal repetition: systematic review and meta-analysis. PLoS One, 9: e89944.
Cipriani, A, Hawton, K, Stockton, S, Geddes, JR (2013) Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ, 346: f3646.
Department of Health (2012) Preventing Suicide in England: A Cross-Government Outcomes Strategy to Save Lives. Department of Health.
Gairin, I, House, A, Owens, D (2003) Attendance at the accident and emergency department in the year before suicide: retrospective study. British Journal of Psychiatry, 183: 28-33.
Hawton, K, Townsend, E, Arensman, E et al (1999) Psychosocial and pharmacological treatments for deliberate self harm. Cochrane Database of Systematic Reviews, 4: CD001764.
Hawton, K, Bergen, H, Casey, D et al (2007) Self-harm in England: a tale of three cities. Multicentre study of self-harm. Social Psychiatry and Psychiatric Epidemiology, 42: 513–21.
Hawton, K, Bergen, H, Simkin, S et al (2010) Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose. British Journal of Psychiatry, 196: 354–8.
Hawton, K, Saunders, KEA, Topiwala, A et al (2013) Psychiatric disorders in patients presenting to hospital following self-harm: a systematic review. Journal of Affective Disorders, 151: 821–30.
Hawton, K, Witt, KG, Taylor Salisbury, TL et al (2015) Pharmacological interventions for self-harm in adults. Cochrane Database of Systematic Reviews, 7: CD011777.
Higgins, JPT, Green, S (eds) (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (Updated March 2011). Cochrane Collaboration.
Lauterbach, E, Felber, W, Müller-Oerlinghausen, B et al (2008) Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial. Acta Psychiatrica Scandinavica, 118: 469–79.
Liang, M (2014) CSP #590 – Lithium for Suicidal Behavior in Mood Disorders (Li+). ClinicalTrials.gov identifier: NCT01928446.
Montgomery, S, Montgomery, D, Jayanthi-Rani, S et al (1979) Maintenance therapy in repeat suicidal behaviour: a placebo controlled trial. In Proceedings of the 10th International Congress for Suicide Prevention and Crisis Intervention, June 17–20, 1979, Ottawa, Canada (eds International Association for Suicide Prevention (Canada), Canadian Mental Health Association): 227–9. Association internationale pour la prevention du suicide (Canada).
Murphy, E, Kapur, N, Webb, R et al (2012) Risk factors for repetition and suicide following self-harm in older adults: multicentre cohort study. British Journal of Psychiatry 200: 399-404.
National Collaborating Centre for Mental Health (2004) Self-Harm: The Short-Term Physical and Psychological Management and Secondary Prevention of Self-Harm in Primary and Secondary Care (Clinical Guideline 16). NICE.
National Institute for Health and Care Excellence (2011) Self-harm in over 8s: Long-Term Management (Clinical Guideline 133). NICE.
Rana, F, Gormez, A, Varghese, S (2013) Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities. Cochrane Database of Systematic Reviews, 4: CD009084.
Ross, BM, Seguin, J, Sieswerda, LE (2007) Omega-3 fatty acids as treatments for mental illness. Which disorder and which fatty acid? Lipids in Health and Disease, 6: 21.
Sinclair, JM, Gray, A, Rivero-Arias, O et al (2011) Healthcare and social services resource use and costs of self-harm patients. Social Psychiatry and Psychiatric Epidemiology, 46: 263–71.
Smith, BD (2005) Self-mutilation and pharmacotherapy. Psychiatry, 2: 28-37.
Stoffers, J, Völlm, BA, Rücker, G et al (2010) Pharmacological interventions for borderline personality disorder. Cochrane Database of Systematic Reviews, 6: CD005653.
Tel-Aviv Sourasky Medical Center (2014) Effect of Oral Ketamine Treatment on Suicidal Ideation and Drug Resistant Major Depression: A Clinical and fMRI Study. ClinicalTrials.gov Identifier: NCT02037503.
Townsend, E (2014) Self-harm in young people. Evidence-Based Mental Health, 17: 97–9.
World Health Organization (2014) Preventing Suicide: A Global Imperative. WHO.
Zahl, DL, Hawton, K (2004) Repetition of deliberate self-harm and subsequent suicide risk: long-term follow-up study of 11583 patients. British Journal of Psychiatry, 185: 70–5.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Advances
  • ISSN: 2056-4678
  • EISSN: 2056-4686
  • URL: /core/journals/bjpsych-advances
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Does drug treatment reduce the risk of further self-harm or suicide?: Commentary on… Cochrane Corner

  • Katharine Smith and Mary Jane Attenburrow
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *